Algorithme Pharma, Vince & Associates Clinical Research and Algorithme Pharma USA’s New Look
LAVAL, QC, CANADA (January 6, 2016) – Altasciences Clinical Research’s companies Algorithme Pharma, Vince & Associates Clinical Research and Algorithme Pharma USA announced today that they are adopting a new look, including new logos.
Algorithme Pharma Announces the Appointment of an Executive Vice President, Phase I Clinical Development
Algorithme Pharma of the Altasciences Group, a full service provider focused on early stage clinical research, today announced the addition of Dr. Graham Wood, Executive Vice President, Phase I Clinical Development to the team.
Dr. Brad Vince Presents at National Institute on Drug Abuse Workshop
Overland Park, KS – Vince & Associates Clinical Research , an Altasciences Clinical Research company, is a leading provider of comprehensive, early development clinical research services for the global biopharmaceutical industry.
Vince & Associates Clinical Research Awarded FDA Contract to Conduct Pharmacokinetic Study with Opioids
Overland Park, KS – Vince & Associates Clinical Research today announced that it has been awarded a contract with the U.S. Food and Drug Administration (FDA) Office of Generic Drugs (OGD) to conduct a clinical pharmacology pharmacokinetic (PK) study of opioids manipulated via
Dr. Brad Vince Named Among PharmaVOICE 100 Most Inspiring People
Overland Park, Kansas - Vince & Associates Clinical Research, a premier provider of early phase clinical research services, is pleased to announce that Dr. Brad Vince, the company’s CEO, founder and medical director, has been named as one of the 100 most inspiring people in the life sciences industry by PharmaVOICE Magazine.